Adaptive Dose-Staged Stereotactic Ablative Body Radiotherapy for Treatment of Large Central NSCLC Lung Tumors: A Dosimetric Simulation Study

被引：0
|
作者：
Rahimian, J. [1 ]
Bhattasali, O. [1 ]
Girvigian, M. R. [2 ]
机构：
[1] Southern Calif Permanente Med Grp, Los Angeles, CA USA
[2] Kaiser Permanente Los Angeles Med Ctr, Los Angeles, CA USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3553
引用
收藏
页码：E709 / E709
页数：1
相关论文
共 50 条
  • [11] Safety of judicious stereotactic ablative radiotherapy for central and ultra-central lung tumors
    Galaverni, Marco
    Colombo, Federico
    Dell'Anna, Cristina
    Lattanzi, Elisabetta
    Grondelli, Claudia
    Salaroli, Francesco
    Renna, Ilaria
    Gianni, Stella
    Ceccon, Giovanni
    Bergamini, Maria Luisa
    D'Abbiero, Nunziata
    Simoni, Nicola
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1706 - S1708
  • [12] Investigating strategies to reduce toxicity in stereotactic ablative radiotherapy for central lung tumors
    Senthi, Sashendra
    Dahele, Max
    Slotman, Ben J.
    Senan, Suresh
    ACTA ONCOLOGICA, 2014, 53 (03) : 330 - 335
  • [13] Identifying dosimetric predictors of toxicity in multiple lung tumors treated with stereotactic ablative radiotherapy (SABR)
    Tekatli, H.
    Tetar, S.
    Warner, A.
    Palma, D.
    Verbakel, W.
    Nguyen, T.
    Spoelstra, F.
    Gaede, S.
    Slotman, B.
    Senan, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S143 - S143
  • [14] Stereotactic body radiotherapy in patients with multiple lung tumors: a focus on lung dosimetric constraints
    Milano, Michael T.
    Mihai, Alina
    Kang, John
    Singh, Deepinder P.
    Verma, Vivek
    Qiu, Haoming
    Chen, Yuhchyau
    Kong, Feng-Ming
    EXPERT REVIEW OF ANTICANCER THERAPY, 2019, 19 (11) : 959 - 969
  • [15] Dose Recomputation Versus Dose Deformation for Stereotactic Body Radiation Therapy in Lung Tumors: A Dosimetric Study
    Ma, M.
    Bayouth, J.
    Flynn, R.
    Xia, J.
    MEDICAL PHYSICS, 2014, 41 (06) : 217 - 217
  • [16] Clinical outcomes following stereotactic ablative body radiotherapy to central lung tumours
    Duong, Julie
    Patel, Riya
    Nariyangadu, Prasana
    Venables, Karen
    Vinayan, Anup
    Harrison, Mark
    Ostler, Peter
    Shah, Nihal
    Tsang, Yat
    Dubash, Suraiya
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S1806 - S1807
  • [17] Recommendations for dose calculations of lung cancer treatment plans treated with stereotactic ablative body radiotherapy (SABR)
    Devpura, S.
    Siddiqui, M. S.
    Chen, D.
    Liu, D.
    Li, H.
    Kumar, S.
    Gordon, J.
    Ajlouni, M.
    Movsas, B.
    Chetty, I. J.
    XVII INTERNATIONAL CONFERENCE ON THE USE OF COMPUTERS IN RADIATION THERAPY (ICCR 2013), 2014, 489
  • [18] Predicting Local Control with Dosimetric Parameters in Patients Receiving Individualized Stereotactic Ablative Radiotherapy for Lung Tumors
    Wu, Y. F.
    Lau, B.
    Fu, J.
    Cui, S.
    Pham, D.
    Dubrowski, P.
    Eswarappa, S.
    Zgrabik, J.
    Candow, L.
    Skinner, L.
    Shirato, H.
    Taguchi, H.
    Gensheimer, M. F.
    Gee, H. E.
    Diehn, M.
    Chin, A. L.
    Loo, B. W., Jr.
    Vitzthum, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E76 - E76
  • [19] DOSIMETRIC STUDY IN LUNG STEREOTACTIC BODY RADIOTHERAPY USING VMAT TECHNIQUES
    Zhang, Geoffrey
    Dilling, Thomas
    Ku, Lichung
    Stevens, Craig
    Li, Weiqi
    Feygelman, Vladimir
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S827 - S828
  • [20] Stereotactic body radiotherapy for central lung tumors, yes we can!
    Yasmin Korzets ceder
    Eyal Fenig
    Aron Popvtzer
    Nir Peled
    Mordechai R. Kramer
    Milton Saute
    Dima Bragilovsky
    Tzippy Schochat
    Aaron M. Allen
    Radiation Oncology, 13
12345